Diprophylline Injection 300mg/2mL (Diprophylline Injection “Eisai”® / ジプロフィリン注300mg「エーザイ」)

JPY ¥1,500

Japanese Cardiotonic and Anti-Asthmatic Agent (Diprophylline 300mg/2mL). For subcutaneous, intramuscular, or intravenous injection in bronchial asthma, asthmatic bronchitis, and congestive heart failure. 10 ampoules (glass ampoules). Mfd. by Eisai Co., Ltd., Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥1,380
10 - 19 12% JPY ¥1,320
20 + 18% JPY ¥1,230
SKU: DIP-300-INJ Category:

Description

Product Overview / 商品概要

Diprophylline Injection 300mg/2mL “Eisai” (ジプロフィリン注300mg「エーザイ」)
Generic: Diprophylline / ジプロフィリン
Therapeutic Category: Cardiotonic and Anti-Asthmatic Agent / 強心・喘息治療剤
Manufactured by: Eisai Co., Ltd. / エーザイ株式会社

Composition & Specification / 組成・規格

Active Ingredient: Diprophylline 300mg per 1 ampoule (2mL) / ジプロフィリン 300mg(1管(2mL)中の分量)
Additives: —
Appearance: Colorless clear solution; pH 5.5–7.5; osmotic pressure ratio approx. 1 (relative to physiological saline)
外観: 無色澄明な液、pH 5.5~7.5、浸透圧比 約1(生理食塩液に対する比)

Indications / 効能効果

EN: Bronchial asthma, asthmatic (or asthma-like) bronchitis, congestive heart failure
JA: 気管支喘息、喘息性(様)気管支炎、うっ血性心不全

Dosage and Administration / 用法用量

EN: The usual adult dose is 300–600mg (1–2 ampoules) of diprophylline per administration, given by subcutaneous, intramuscular, or intravenous injection. Dosage may be adjusted according to age and symptoms.
JA: ジプロフィリンとして、通常成人1回300~600mg(1~2管)を皮下、筋肉内または静脈内注射する。なお、年齢、症状により適宜増減する。

Contraindications / 禁忌

EN: Patients with a history of serious adverse reactions to this product or other xanthine-class drugs
JA: 本剤又は他のキサンチン系薬剤に対し重篤な副作用の既往歴のある患者

Regulatory Information / 規制情報

Approval No.: 22000AMX02175000
Sales Started: October 1952 / 1952年10月
Classification Code: 872115
Storage: Store at room temperature / 室温保存
Shelf Life: 3 years / 3年

Packaging / 包装

Main Package (for sale): 10 ampoules (glass ampoules) / 10管(ガラスアンプル)
Other Available Packages (by special order): 10 ampoules, 50 ampoules (glass ampoules)

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Diprophylline Injection 300mg/2mL (Diprophylline Injection “Eisai”® / ジプロフィリン注300mg「エーザイ」)”

メールアドレスが公開されることはありません。 ※ が付いている欄は必須項目です

Export from Japan — Diprophylline Injection 300mg

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.